Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

12/02/2019 06:30

Feb 12 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.88               13.18            17.97    
                 (-2.3 pct)          (+2.7 pct)       (+2.9 pct)  
  Operating        568 mln             751 mln            1.04    
                 (-24.4 pct)         (+37.4 pct)      (+2.4 pct)  
  Recurring        586 mln             774 mln            1.06    
                 (-24.2 pct)         (+34.8 pct)      (+0.5 pct)  
  Net              378 mln             515 mln          716 mln   
                 (-26.5 pct)         (+37.9 pct)      (+4.6 pct)  
  EPS            110.24 yen          148.17 yen       207.05 yen  
  Ann Div                             11.00 yen        10.00 yen  
  -Q2 div                                NIL                      
  -Q4 div                             11.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T